Anti-CD47 antibody: A new hope for cancer treatment

The efficiency and precision of cancer treatments, which may be surgical removal, radiotherapy, chemotherapy, or a combination of second and third depends upon the stage and type of cancer. Targeting CD47 and Signal inhibitory receptor alpha protein interactions (SIRPα) has evolved as one of several such methods of cancer therapy. Continue reading Anti-CD47 antibody: A new hope for cancer treatment